IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9453007 B1

PDFFull Text
Date of Patent:
Sep. 27, 2016

Filed:

Sep. 14, 2015

Hepatitis c inhibitors and uses thereof

Applicants:

Abbvie Inc., North Chicago, IL (US);

Abbott Products Gmbh, Hannover, DE;

Inventors:

Clarence J. Maring, Palatine, IL (US);

John K. Pratt, Kenosha, WI (US);

William A. Carroll, Evanston, IL (US);

Dachun Liu, Vernon Hills, IL (US);

David A. Betebenner, Libertyville, IL (US);

Douglas K. Hutchinson, Antioch, IL (US);

Michael D. Tufano, Chicago, IL (US);

Todd W. Rockway, Grayslake, IL (US);

Uwe Schoen, Burgdorf, DE;

Axel Pahl, Lindwedel, DE;

Andreas Witte, Hannover, DE;

Assignees:

ABBVIE INC., North Chicago, IL (US);

ABBOTT PRODUCTS GMBH, Hannover, DE;

Attorney:

Neal, Gerber & Eisenberg LLP

Primary Examiner:

Kahsay Habte

Int. Cl.
CPC ...
C07D 413/14 (2006.01); C07D 413/04 (2006.01); A61K 31/5395 (2006.01); C07D 405/04 (2006.01); C07D 405/14 (2006.01); C07D 409/14 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07F 7/18 (2006.01); A61K 31/4178 (2006.01); A61K 31/422 (2006.01); A61K 31/4245 (2006.01); A61K 31/427 (2006.01); A61K 31/437 (2006.01); A61K 31/513 (2006.01); A61K 31/5377 (2006.01); A61K 31/541 (2006.01); A61K 31/675 (2006.01); A61K 45/06 (2006.01); C07F 9/6558 (2006.01);
U.S. Cl.
CPC ...
C07D 413/04 (2013.01); A61K 31/4178 (2013.01); A61K 31/422 (2013.01); A61K 31/427 (2013.01); A61K 31/4245 (2013.01); A61K 31/437 (2013.01); A61K 31/513 (2013.01); A61K 31/5377 (2013.01); A61K 31/5395 (2013.01); A61K 31/541 (2013.01); A61K 31/675 (2013.01); A61K 45/06 (2013.01); C07D 405/04 (2013.01); C07D 405/14 (2013.01); C07D 409/14 (2013.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07F 7/1856 (2013.01); C07F 9/65586 (2013.01);
Abstract

This disclosure relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.

Find Patent Forward Citations

Loading…